TOP TIERMARKET NEWSWIRE
News & sentiment

ASCENDIS PHARMA A/S (ASND) — News & AI sentiment

ASCENDIS PHARMA A/S (ASND) news roundup. 1 story in the last 24 hours, 12 in the past week, 42 over 30 days. Average 24-hour sentiment is 63/100 — bullish-leaning (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 1 purchases totalling $493K and 1 sales totalling $811K — net selling of $318K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 63/100
7d stories
12
avg sentiment 59/100
30d stories
42
avg sentiment 59.1/100
Insider net (90d)
$318K
1 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

ASND news in the last 24 hours, 7 days, 30 days and 90 days

How much ASND coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowASND storiesAvg AI sentimentRead
Last 24 hours163/100ASND headlines →
Last 7 days1259/100ASND headlines →
Last 30 days4259.1/100ASND headlines →
Last 90 days5859.4/100ASND headlines →

Latest stories on ASND

17h ago
H.C. Wainwright reiterates Ascendis Pharma stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
3d ago
TD Cowen reiterates Buy on Ascendis Pharma stock on infant data
Investing.com Analyst Ratings61 · neutralanalyst
3d ago
BMO reiterates Ascendis Pharma stock rating on infant trial data
Investing.com Analyst Ratings56 · neutralanalyst
3d ago
4d ago
4d ago
4d ago
4d ago
5d ago
5d ago
6d ago
6d ago
Sep 4
Sep 2
Oppenheimer raises Ascendis Pharma stock price target on settlement
Investing.com Analyst Ratings63 · neutralanalyst
Sep 1
BofA cuts Ascendis Pharma stock price target on settlement impact
Investing.com Analyst Ratings38 · neutralanalyst
Sep 1
Sep 1
Aug 31
Jefferies raises BioMarin stock price target on Ascendis settlement
Investing.com Analyst Ratings63 · neutralanalyst
Aug 31
Aug 31
Aug 31
Ascendis Pharma rises 8.0%
The Fly56 · neutralgeneral
Aug 31
Aug 31
Aug 31
Aug 31
Open ASND in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →